Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Junichi, Mitsuyama"'
Autor:
Nobuhiko Nomura, Kohei Yamashita, Noritomo Fujino, Yusuke Koizumi, Hiroyuki Suematsu, Hiroki Watanabe, Eio Yamada, Toru Sakagami, Junichi Mitsuyama, Yoshiko Fukuda, Yuka Yamagishi, Takaki Kawano, Makoto Kaeriyama, Hiroshige Mikamo, Nobuhiro Asai
Publikováno v:
Journal of Infection and Chemotherapy. 25:34-40
We compared the susceptibility of six commercially available antifungal agents (fluconazole, itraconazole, voriconazole, caspofungin, micafungin, and amphotericin B) against 133 Candida bloodstream isolates between 2008 and 2013 at Aichi Medical Univ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c1d828c7de91a38f7e16ab8c0f7fa07
https://doi.org/10.1016/j.jiac.2018.10.007
https://doi.org/10.1016/j.jiac.2018.10.007
Autor:
Junichi Mitsuyama, April Connell, Yoshiko Fukuda, Rosie Jaramillo, Thomas F. Patterson, Nathan P. Wiederhold, Hoja P Patterson, Laura K. Najvar, Marcos Olivo, Gabriel Catano
Publikováno v:
Antimicrob Agents Chemother
The in vitro and in vivo activity of the arylamidine T-2307 against Candida auris was evaluated. T-2307 demonstrated in vitro activity (MIC ranges ≤ 0.008 to 0.015 μg/ml at 50% inhibition; 0.125 to >4 μg/ml at 100% inhibition).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db36e547730c65248c216d02848e07a6
https://europepmc.org/articles/PMC7038306/
https://europepmc.org/articles/PMC7038306/
Autor:
Shintaro Shimamura, Katsunori Yanagihara, Junichi Mitsuyama, Shigeru Kohno, Tomomi Saijo, Yoshifumi Imamura, Hiroshi Mukae, Kazuko Yamamoto, Kohei Yamashita, Taiga Miyazaki, Yoshiko Fukuda, Koichi Izumikawa
Publikováno v:
Antimicrobial Agents and Chemotherapy
The novel arylamidine T-2307 exhibits broad-spectrum in vitro and in vivo antifungal activities against clinically significant pathogens. Previous studies have shown that T-2307 accumulates in yeast cells via a specific polyamine transporter and disr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34325a07b88cf438c3d37070bf7c075d
http://europepmc.org/articles/PMC6658782
http://europepmc.org/articles/PMC6658782
Autor:
Tatsuya Shibata, Yuka Yamagishi, Hiroshige Mikamo, Satoshi Nakagawa, Junichi Mitsuyama, Nobuhiko Nomura
Publikováno v:
Japanese journal of infectious diseases. 70(6)
The pharmacokinetic-pharmacodynamic (PK-PD) breakpoints (BPs) of garenoxacin (GRNX) and other oral quinolones were calculated using Monte Carlo simulation (MCS) based on the distribution of changes in their plasma concentrations. PK-PD BPs of 400 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9de71a304f114a58c1fc4d617307b4e
https://pubmed.ncbi.nlm.nih.gov/28890509
https://pubmed.ncbi.nlm.nih.gov/28890509
Autor:
Yuka Yamagishi, Yuri Furuya, Maki Eto, Hiroshige Mikamo, Hayato Okade, Nobuhiko Nomura, Takumi Kadota, Junichi Mitsuyama, Tori Funatsu
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 23(6)
The introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in February 2010 markedly reduced the burden of invasive pneumococcal disease and changed serotype distribution in Japan. In November 2013, PCV7 was replaced by the 13-valent pneu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b82138fdba4e47655f6ba0f0cfa8b9aa
https://pubmed.ncbi.nlm.nih.gov/28427991
https://pubmed.ncbi.nlm.nih.gov/28427991
Autor:
Hayato Okade, Toru Sakagami, Satoshi Nakagawa, Harumi Hisada, Nobuhiko Nomura, Junichi Mitsuyama, Yuka Yamagishi, Hiroshige Mikamo
Publikováno v:
Journal of Infection and Chemotherapy. 20:778-783
The spread of plasmid-mediated quinolone resistance (PMQR) determinants was evaluated in 150 ceftazidime or cefotaxime-resistant clinical isolates of Klebsiella pneumoniae and Escherichia coli from Tokai, Japan between 2008 and 2011. In this study, q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd5e3fb4ad05c635e36a7ee1e80052f5
https://doi.org/10.1016/j.jiac.2014.08.018
https://doi.org/10.1016/j.jiac.2014.08.018
Autor:
Hayato Okade, Hiroshige Mikamo, Tori Funatsu, Yuka Yamagishi, Shingo Mizunaga, Junichi Mitsuyama, Nobuhiko Nomura, Maki Eto, Yuri Furuya
Publikováno v:
Journal of Infection and Chemotherapy. 20:423-428
Introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in February 2010 markedly reduced the burden of invasive pneumococcal disease (IPD) and changed serotype distribution in Japan. We investigated the serotype distribution and susceptib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a955b4c6f2647d3e1404fe529613f00e
https://doi.org/10.1016/j.jiac.2014.03.010
https://doi.org/10.1016/j.jiac.2014.03.010
Autor:
Thomas F. Patterson, Annette W. Fothergill, Laura K. Najvar, Marcos Olivo, Nathan P. Wiederhold, Dora I. McCarthy, Junichi Mitsuyama, Rosie Bocanegra, Yoshiko Fukuda, William R. Kirkpatrick
Publikováno v:
Antimicrobial Agents and Chemotherapy. 59:1341-1343
We evaluated the in vitro and in vivo activities of the investigational arylamidine T-2307 against echinocandin-resistant Candida albicans . T-2307 demonstrated potent in vitro activity, and daily subcutaneous doses between 0.75 and 6 mg/kg of body w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d533054109b143bdecb3c550904a8d
https://doi.org/10.1128/aac.04228-14
https://doi.org/10.1128/aac.04228-14
Autor:
Hiroshi Kakeya, Yoshifumi Imamura, Yoshiko Fukuda, Shigeru Kohno, Katsunori Yanagihara, Tomomi Saijo, Shigeki Nakamura, Taiga Miyazaki, Kazuko Yamamoto, Junichi Mitsuyama, Akitaka Tanaka, Hiroshi Mukae, Yoshihiro Yamamoto, Hiroshi Nishikawa, Masato Tashiro, Koichi Izumikawa, Takahiro Takazono
Publikováno v:
The Journal of antimicrobial chemotherapy. 72(6)
Objectives T-2307, a novel arylamidine, exhibits potent broad-spectrum activities against the majority of fungal pathogens. In this study, the antifungal activity of T-2307 against Cryptococcus gattii was evaluated in comparison with those of amphote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f7d4a684a16ddf611b49e1fbab17af7
https://pubmed.ncbi.nlm.nih.gov/28201509
https://pubmed.ncbi.nlm.nih.gov/28201509
Autor:
Hiroyoshi Hayakawa, Eio Yamada, Tatsuya Shibata, Hiroshi Nishikawa, Junichi Mitsuyama, Akiko Kimura, Toshinari Takahashi, Nobuhiko Nomura
Publikováno v:
Antimicrobial Agents and Chemotherapy. 56:5892-5897
T-2307, an arylamidine compound, has been previously reported to have broad-spectrum in vitro and in vivo antifungal activities against clinically significant pathogens, including Candida species, Cryptococcus neoformans , and Aspergillus species, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe513f31279108e547a256f262c258ef
https://doi.org/10.1128/aac.05954-11
https://doi.org/10.1128/aac.05954-11